HCA Healthcare Surges to 170th in Trading Volume with 9.68 Billion Shares Exchanged

On April 9, 2025, HCA Healthcare (HCA) saw a significant increase in trading volume, reaching 9.68 billion, a 39.6% rise from the previous day. This surge placed HCA at the 170th position in terms of trading volume for the day. The stock price of HCA also rose by 1.91%, marking the second consecutive day of gains, with a total increase of 2.70% over the past two days.

HCA Healthcare UK, a leading private healthcare provider, has introduced an advanced robotic-assisted surgical method for thoracic patients at London Bridge Hospital. This innovative approach utilizes the da Vinci SP (Single Port) system, allowing for complex surgeries through a single 5cm incision. The procedure, led by Consultant Thoracic Surgeon Mr. Tom Routledge, is particularly beneficial for lung cancer patients, enabling them to return to daily life with minimal discomfort.

The da Vinci SP system, developed by Intuitive, was first made available to UK patients in March 2024 for urological conditions. Since then, the team at London Bridge Hospital has performed over 300 procedures using this system. The system's design, featuring three multi-jointed, wristed instruments and a fully wristed 3D, HD camera, allows for precise surgery through a single incision, reducing post-operative discomfort and expanding the eligibility for robotic-assisted surgery.

Mr. Routledge and his team underwent extensive training, including simulation and lab work, supervised by world-leading experts from South Korea and New York. The da Vinci SP system is part of HCA UK’s fleet of 8 da Vinci Xi surgical systems, with over 16,000 robotic-assisted procedures performed across their network in the past nine years. This development underscores HCA UK’s commitment to advancing robotic surgery, offering patients enhanced surgical options and quicker recovery times.